Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02310464
Title Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors OBI Pharma, Inc
Indications

lung non-small cell carcinoma

colorectal cancer

stomach cancer

lung cancer

breast cancer

Therapies

OBI-821 + OBI-833

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Taipei Medical University Shuang Ho Hospital New Taipei City 23561 Taiwan Details
National Taiwan University Hospital Taipei 10002 Taiwan Details
Taipei Medical University Hospital Taipei 11031 Taiwan Details
Tri-Service General Hospital Taipei 114 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field